Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment and self-reported side effects in the euthymic phase of bipolar disorders: Results from the FACE-BD cohort.
Vidal N, Brunet-Gouet E, Frileux S, Aouizerate B, Aubin V, Belzeaux R, Courtet P, D'Amato T, Dubertret C, Etain B, Haffen E, Januel D, Leboyer M, Lefrere A, Llorca PM, Marlinge E, Olié E, Polosan M, Schwan R, Walter M; FACE-BD (FondaMental Academic Centers of Expertise for Bipolar Disorders) group; Passerieux C, Roux P.
Vidal N, et al. Among authors: frileux s.
Eur Neuropsychopharmacol. 2023 Dec;77:67-79. doi: 10.1016/j.euroneuro.2023.08.502. Epub 2023 Sep 21.
Eur Neuropsychopharmacol. 2023.
PMID: 37741163